Imaging brain tumors with a new tracer
Part of Cancer clinical trials.
This trial tests a new imaging tracer called MeFAMP to see if it can help doctors see brain tumors more clearly on PET scans. It may help guide treatment for people with brain tumors that have come back or spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a brain tumor that is either high-grade glioma (grade III or IV) that has been treated with radiation and shows a suspicious area on MRI, or a brain metastasis from melanoma, lung cancer, or breast cancer that is at least 1 cm on MRI.
- You are able to undergo PET scans.
- You have a life expectancy of more than 12 weeks.
- You do not have significant kidney or liver problems.
- You have not used an investigational drug in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special PET and MRI scans to map the activity and oxygen levels of brain tumors (gliomas). The results help doctors plan treatment that is more tailored to each patient.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
Hear when a new Recurrent Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.